Irvine, California — According to state and local economic development sources Edwards Lifesciences plans to invest $5,694,683.28 to build out 59,098 square feet of new space in Irvine. The company plans to occupy the new space at 1442 Alton Pkwy in Irvine, on or about September 1, 2023. According to the company website Edwards Lifesciences (NYSE: EW), is the global leader in patient-focused medical innovations for structural heart disease, as well as critical care and surgical monitoring. We thrive on discovery and expanding the boundaries of medical technology, serving patients in 100+ countries, with the help of our employees in areas including Clinical Affairs, Quality Engineering, Research & Development, Regulatory Affairs, Sales & Marketing, corporate functions and more. Our roots date back to 1958 when Miles Lowell Edwards, a retired engineer with a background in hydraulics and fuel pump operations, set out to build the first artificial heart. Edwards believed the heart could be mechanized and was encouraged by Dr. Albert Starr to focus on developing an artificial heart valve. After just two years, the first Starr-Edwards mitral valve was developed and successfully placed in a patient. This innovation spawned Edwards Laboratories. Miles fascination with healing the heart and helping patients with heart disease stemmed from his own experience with rheumatic fever as a teenager and continues to fuel our patient-first culture today. Today, we are as passionate about providing innovative solutions for people fighting cardiovascular disease as we have ever been.

To learn more about Edwards Lifesciences, visit http://www.edwards.com/

Company Contact:
Michael Mussallem, Chief Executive Officer
800-424-3278

SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved